Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Peripheral Arterial Disease Clinical Trials

33 recruiting trials for Peripheral Arterial Disease. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
33
Total Trials
33
Recruiting Now
1
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT06124586

Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)

The planned study is a Randomized Controlled Monocentric Trial, which will provide evidence on whether early angiography in percutaneous transluminal angioplasty (PTA) readiness...

Sponsor: Heinrich-Heine University, DuesseldorfEnrolling: 2001 location
RECRUITINGNCT06009276

Associations Between the Microbiome, Skeletal Muscle Perfusion, and Fitness Status

The purpose of the study is to determine associations between fitness status, bacteria in the mouth, and the blood flow to muscle. This study is trying to find out if fitness...

Sponsor: University of VirginiaEnrolling: 701 location
RECRUITINGNCT06253312

Treatment of TASC C and D Aortoiliac Lesions

Background: The treatment of patients with complex aortoiliac disease (AID), classified as Trans-Atlantic Inter-Society consensus II (TASC) class C and D, presents a dilemma for...

Sponsor: Clinical Centre of SerbiaEnrolling: 9001 location
RECRUITINGPhase 2NCT06399809

Fisetin to Reduce Senescence and Mobility Impairment in PAD

The investigators propose a pilot randomized trial to gather preliminary data to test the hypothesis that Fisetin will reduce abundance of senescent cells in blood, skeletal...

Sponsor: Northwestern UniversityEnrolling: 341 location
RECRUITINGPhase 4NCT02842424

Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis

Peripheral artery disease (PAD) is a manifestation of atherosclerosis that produces progressive narrowing and occlusion of the arteries supplying the lower extremities. The most...

Sponsor: University of NebraskaEnrolling: 701 location
RECRUITINGNCT05612945

High-intensity Intervals Versus Low-to-moderate-intensity Exercise Training in Patients With PAD

Supervised exercise training (SET) is considered among first-line therapies for patients with symptomatic lower extremity peripheral artery disease (PAD), combined with general...

Sponsor: Centre Hospitalier Universitaire VaudoisEnrolling: 601 location
RECRUITINGNCT04027244

Leg Ischaemia Management Collaboration

Single-centre prospective cohort study of patients presenting with severe limb ischaemia (SLI). The primary outcome measure will be 12 month major amputation rate. A historical...

Sponsor: University of LeicesterEnrolling: 4201 location
RECRUITINGNCT06832631

VITUS Post-Market Registry

To collect post marketing surveillance data on consecutive patients with peripheral arterial occlusive disease (PAOD) intended to be or treated by the VITUS peripheral drug-coated...

Sponsor: OrbusNeichEnrolling: 28413 locations
RECRUITINGNCT06887101

Impact of Stress on Cardiovascular Events in Patients with Peripheral Arterial Disease

Atherosclerotic cardiovascular disease is the leading cause of morbidity and mortality worldwide. Patients with peripheral arterial disease are at increased risk suffering from...

Sponsor: University Hospital, EssenEnrolling: 3001 location
RECRUITINGPhase 4NCT06873321

VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization

Venous thromboembolism (VTE) has a high prevalence in patients with multiple comorbidities undergoing complex surgical procedures. Sometimes, extended prophylaxis for VTE with...

Sponsor: Science Valley Research InstituteEnrolling: 1001 location
RECRUITINGNCT06275113

BRING-UP Prevention

The aim of this observational study is to assess in patients with a documented athero-thrombotic event: coronary artery disease (CAD), cerebrovascular disease (CVD), peripheral...

Sponsor: Heart Care FoundationEnrolling: 600020 locations
RECRUITINGNCT07427108

Road Mapping Guided Puncture Versus Ultrasound Guided Puncture During Retrograde Angioplasty Feasibility and Safety

The study aims to compare the technical feasibility and safety of road mapping-guided versus ultrasound-guided retrograde arterial puncture in patients with (CLTI) as measured by:...

Sponsor: Sohag UniversityEnrolling: 321 location
RECRUITINGEarly Phase 1NCT06319339

Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease

Peripheral artery disease (PAD) is associated with elevated oxidative stress, and oxidative stress has been implicated as the cause of reduced endothelial reactivity in...

Sponsor: University of NebraskaEnrolling: 201 location
RECRUITINGNCT04188808

Prospective Case-control Study in Patients With PAA

The overall objective is to highlight different aspects of care in patients with PAA before and after treatment, and identifying factors that influence the outcome of PAA patients.

Sponsor: Rebecka HultgrenEnrolling: 1302 locations
RECRUITINGPhase 3NCT06032065

SMART Exercise for PAD

Supervised exercise therapy (SET), consisting of treadmill exercise conducted three times weekly at a center while supervised by healthcare personnel, is first line therapy for...

Sponsor: Northwestern UniversityEnrolling: 2103 locations
RECRUITINGNCT04912323

Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease

This first-in-human clinical feasibility study will evaluate the safety and performance of the R3 Vascular MAGNITUDE® Bioresorbable Drug-Eluting Scaffold and Delivery System in...

Sponsor: R3 Vascular Inc.Enrolling: 307 locations
RECRUITINGNCT07472049

Symptomatic and Systemic Atherosclerotic Plaque Activity in Patients With Peripheral Arterial Disease Using Novel...

The goal of this observational study is to characterise the relationships between inflammation, microcalcification and thrombus activity in atherosclerotic plaques in peripheral...

Sponsor: University of EdinburghEnrolling: 1001 location
RECRUITINGNCT06112171

Comparison of a Lithotripsy vs Standard Preparation Followed by Stenting With Supera Stent in Femoropopliteal Lesions

This study is an investigator-initiated, prospective, single-center, 1:1 randomized pilot study. The trial evaluates the safety and efficacy of intravascular lithotripsy in...

Sponsor: University of LeipzigEnrolling: 1201 location
RECRUITINGNCT06566976

Prehabilitation and Rehabilitation in PAD

To determine the effectiveness of pre and post-operative exercise therapy in patients undergoing peripheral artery stenting for peripheral arterial disease.

Sponsor: Palo Alto Veterans Institute for ResearchEnrolling: 3001 location
RECRUITINGNCT06758921

Prospective, Multicenter, Single-Arm Observational Study to Confirm the Safety and Clinical Performance of the Oscar...

The purpose of this study is to evaluate the standard of care practices, procedural outcomes, and in-hospital complications for endovascular peripheral interventions of femoral,...

Sponsor: Biotronik AGEnrolling: 20016 locations
RECRUITINGNCT06237621

Using SnapshotNIR With Provocative Leg Maneuver for PAD Assessment

The objective of this trial is to determine if Near-infrared spectroscopy (NIRS) can accurately evaluate the degree of Peripheral Arterial Disease (PAD) during a Provocative...

Sponsor: Kent Imaging IncEnrolling: 1501 location
RECRUITINGNCT06391346

Investigation of the Perfusion of Gluteal Muscle in Patients With Intermittent Gluteal Claudication by Non-invasive MSOT

The objective of the proposed study is to define independent parameters for the diagnostic assessment of the perfusion situation of the gluteal muscle based on multispectral...

Sponsor: Ulrich RotherEnrolling: 201 location
RECRUITINGPhase 4NCT05854641

Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease

The goal of this observational, practice-based feasibility study is to observe the efficacy and safety of intramuscular administration of Stempeucel® in Malaysian patients with...

Sponsor: Cell Biopeutics Resources Sdn BhdEnrolling: 101 location
RECRUITINGNCT05145478

CRUSH PAD: Real-world Outcomes Following Use of Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified...

The primary goal of the study is to obtain effect size data on the use of Shockwave Intravascular Lithotripsy (IVL) technology in calcified common femoral lesions in patients with...

Sponsor: Yale UniversityEnrolling: 502 locations
RECRUITINGNCT07353905

Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries

This study will test whether using ultrasound imaging within blood vessels during minimally invasive treatment of leg arteries in patients with peripheral artery disease leads to...

Sponsor: Baylor Research InstituteEnrolling: 3506 locations
RECRUITINGNCT06277362

Peripheral Extreme Revascularization in "No-option" Patiens With Chronic Limb Threatening Ischemia

The objective of the study is to evaluate early safety and effectiveness of the percutaneous deep foot venous arterialization performed in clinical practice, in an unselected...

Sponsor: EndoCore Lab s.r.l.Enrolling: 509 locations
RECRUITINGNCT07122167

Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for...

This is a prospective, multi-center, single-arm post-market study evaluating the safety and effectiveness of the ZENFLEX Pro™ Drug-eluting Stent in treating femoropopliteal artery...

Sponsor: MDCECRO LLCEnrolling: 1531 location
RECRUITINGNCT05701293

A ProspeCtive mUlticenteR Investigation on RENzar Stent Safety and Efficacy in the Treatment of Patients With...

CURRENT Registry is a physician-initiated prospective, multicenter, post-market, single-arm study with a plan to include approximately 100 patients eligible to be treated with...

Sponsor: Azienda Ospedaliera Universitaria SeneseEnrolling: 1001 location
RECRUITINGPhase 2NCT06420752

Passive Stretching in Peripheral Arterial Disease Patients

Peripheral artery disease (PAD) leads to higher mortality rates and strains healthcare systems due to increased costs. It causes leg pain during walking due to reduced blood flow....

Sponsor: University of Wisconsin, La CrosseEnrolling: 641 location
RECRUITINGNCT06250790

Selective Coronary Revascularization in Peripheral Artery Disease Patients (SCOREPAD Trial)

The primary objective of this study is to determine whether among symptomatic Peripheral Arterial Disease (PAD) patients with no known Coronary Artery Disease (CAD) who had...

Sponsor: Pauls Stradins Clinical University HospitalEnrolling: 6001 location
RECRUITINGNCT07497360

Tele-assessment and Face-to-face Assessment of the 30-second Sit-stand Test in Peripheral Artery Disease

Peripheral artery disease (PAD) is a chronic and progressive condition caused by narrowing or blockage of arteries in the lower limbs due to atherosclerosis. It primarily affects...

Sponsor: Izmir Democracy UniversityEnrolling: 451 location
RECRUITINGNCT06806540

The Frequency of Peripheral Arterial Disease in Patients with Deep Vein Thrombosis of the Lower Limbs

The aim of the study is to assess the frequency of Peripheral Arterial Disease (PAD) and cardiovascular risk factors in patients with unprovoked Deep Vein Thrombosis (DVT) of the...

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di BolognaEnrolling: 4401 location
RECRUITINGNCT02280733

A Real-World Registry of Chronic Wounds and Ulcers

WOUNDJOURNEY is a longitudinal, real-world, observational registry designed to capture the full clinical course and patient journey associated with chronic wounds and ulcers. Data...

Sponsor: U.S. Wound RegistryEnrolling: 3000001 location

Frequently Asked Questions

There are currently 33 clinical trials for Peripheral Arterial Disease, with 33 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Peripheral Arterial Disease, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 1 Phase 3 trials for Peripheral Arterial Disease, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice — always talk to your doctor about clinical trial participation.